Antitumor Potential of Substances from the Fungus Ganoderma lucidum


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We present here a review of published data mostly from the last 10 years on the antitumor activity of substances from the fungus Ganoderma lucidum. Its main biologically active components are described, particularly triterpenes, polysaccharides, glycoproteins, and proteoglycans. The mechanisms of the antitumor actions of these compounds in vitro and in vivo are discussed, these including blockade of the cell cycle, induction of apoptosis, decreases in the metastatic potential, suppression of angiogenesis, and immunomodulatory activity. The potential of using substances from G. lucidum for the treatment of oncological patients is assessed.

About the authors

E. S. Petrova

Science Research Institute of Therapy and Prophylactic Medicine, Russian Academy of Sciences; Institute of Solid Body Chemistry and Mechanistic Chemistry

Email: chem@folium.ru
Russian Federation, 175/1 B. Bogatkov Street, Novosibirsk, 630089; 18 Kutateladze Street, Novosibirsk, 630128

M. I. Rudina

Science Research Institute of Therapy and Prophylactic Medicine, Russian Academy of Sciences

Email: chem@folium.ru
Russian Federation, 175/1 B. Bogatkov Street, Novosibirsk, 630089

Ya. Sh. Shvarts

Novosibirsk Science Research Institute of Tuberculosis, Russian Ministry of Health

Email: chem@folium.ru
Russian Federation, 81a Okhotskaya Street, Novosibirsk, 630040


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies